NoAb BioDiscoveries is a contract research organization (CRO) that offers a wide range of pharmaceutical drug biologic and development services. As a cutting edge drug discovery CRO located in the heart of North America's key biotech hubs, NoAb BioDiscoveries helps to shape and optimize drug discovery research through the provision of a wide range of specialized and proprietary research services. These research services focus on lead selection and optimization using innovative tools and technologies that accelerate the drug discovery process and ensure success. The research facility houses state-of-the-art instrumentation that includes LC-MS/MS, HPLC and fluorescent detection equipment to provide quality discovery services in a timely and efficient manner. All the services are conducted in-house by highly trained and experienced scientists under strict guidelines that ensure quality, efficiency and timeliness.
The drug discovery CRO is committed to:
" Accelerating the drug discovery process, reducing costs and maximizing your success.
" Providing accurate and reliable results through the superior scientific procedures available.
" Using innovation to build the future of drug discovery research.
" Developing long term relationships.
" Achieving complete customer satisfaction.
NoAb BioDiscoveries continues on the path to delivering premier drug discovery services to its clients and ensuring their success by consistently developing advanced research tools to better characterize the pharmacokinetic properties of drug candidates, optimizing the selection of viable clinical candidates.
NoAb BioDiscoveries is a drug discovery CRO that specializes in in vivo pharmacokinetics studies, in vitro ADME assays, bioanalysis and gene expression assays. These services offer clients the ability to profile compounds for the selection of the best candidates for further pre-clinical and clinical development. The team of experienced scientists skillfully designs and performs standard and specialized assays according to customer specifications by identifying the best strategies and protocols suited to any drug discovery need. Detailed information on the numerous pharmacokinetic studies, ADME profiling assays and gene expression assays is available at www.noabbiodiscoveries.com. Each of the assays available is intended to produce accurate and reliable information that allows the selection of suitable leads that can be optimized into promising drug candidates in the shortest time possible.
At NoAb BioDiscoveries you get the full range of discovery services needed to identify viable new drug candidates for further development into phase I trials in humans. The drug discovery CRO offers high quality and highly efficient high throughput ADME profiling that provides accurate information on suitable leads. However, drug discovery requires that this information be properly interpreted and extrapolated to in vivo situations for a better understanding of pharmacokinetic studies no matter how reliable and accurate the information generated from ADME assays is. NoAb BioDiscoveries offers you the full range of in vitro and in vivo services required for drug discovery so that you can get all the information necessary in one place and shorten the time required to market your new drug candidate. By offering a comprehensive range of standard and specialized services, NoAb BioDiscoveries provides exceptional services at affordable costs to you so that you can maximize your profits and ultimately reduce the time to market for new drugs. Beat the competition in the market by having this drug discovery CRO provide you with optimized leads that can be developed into promising new drug candidates in a short turnaround time!
